Search Results - "WEILLER, E"

Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: Results from post hoc analyses by Azorin, J.M, Sapin, C, Weiller, E

“…Abstract Background The efficacy of agents useful for mania is largely unproven in patients with mixed episodes. Methods The efficacy of asenapine in the…”
Get full text

DSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data by McIntyre, R.S, Tohen, M, Berk, M, Zhao, J, Weiller, E

“…Abstract Background To describe the frequency of mixed specifier as proposed in DSM-5 in bipolar I patients with manic episodes, and to evaluate the effect of…”
Get full text

Effect of brexpiprazole on weight and metabolic parameters: analysis of a maintenance trial in schizophrenia by Weiss, C, Weiller, E, Hobart, M, Ouyang, J

Get full text

P2.f.018 Effect of adjunctive brexpiprazole (OPC-34712) on depressive symptoms in patients with symptoms of anxious distress: results from post-hoc analyses by Weiller, E, McIntyre, R.S, Zhang, P, Weiss, C

Get full text

Efficacy and safety of brexpiprazole in schizophrenia: Meta-analysis of three double-blind, randomized, placebo-controlled phase 3 studies by Weiss, C, Zhang, P, Hakala, M.J, Skuban, A, Weiller, E

“…Introduction Brexpiprazole is a serotonin-dopamine activity modulator that is a partial agonist at 5-HT1A and dopamine D2 receptors at similar potency, and an…”
Get full text

Effect of adjunctive brexpiprazole on functioning in three exploratory, open-label studies in major depressive disorder by Baker, R, Matsushima, Y, Tsuneyoshi, K, Weiss, C, Skuban, A, Weiller, E

Get full text

P.2.f.025 Switching from inadequate adjunctive treatments: Open-label study of brexpiprazole effects on depressive symptoms, cognitive and physical functioning by Baker, R, Okame, T, Perry, P, Matsushima, Y, Weiller, E

Get full text

The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI by Lecrubier, Y, Sheehan, DV, Weiller, E, Amorim, P, Bonora, I, Harnett Sheehan, K, Janavs, J, Dunbar, GC

“…The Mini International Neuropsychiatric Interview (MINI) is a short diagnostic structured interview (DSI) developed in France and the United States to explore…”
Get full text

An interventional, multi-center, randomized, double-blind, placebo-controlled, active reference, flexible dose study of brexpiprazole in adults with acute schizophrenia by Marder, S.R, Hakala, M, Gislum, M, Skuban, A, Weiller, E, Weiss, C

“…Introduction Brexpiprazole is a serotonin-dopamine activity modulator that is a partial agonist at 5-HT1A and dopamine D2 receptors at similar potency, and an…”
Get full text

P.2.f.026 Adjunctive brexpiprazole (OPC-34712) in young patients with major depressive disorder who are working or at school: an exploratory study by Baker, R, Ota, A, Perry, P, Tsuneyoshi, K, Weiller, E, Weisler, R, Sheehan, D.V

Get full text

P.3.d.063 Brexpiprazole (OPC-34712) vs aripiprazole in adults with acute schizophrenia: a multicenter, randomized, open-label, flexible-dose, exploratory study by Citrome, L, Ota, A, Nagamizu, K, Perry, P, Weiller, E, Baker, R

Get full text

P.3.d.072 Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies by Correli, C, Skuban, A, Ouyang, J, Weiss, C, Weiller, E, Kane, J.M

Get full text

P.3.d.071 The effect of brexpiprazole (OPC-34712) in adult outpatients with early-episode schizophrenia: An exploratory study by Weiss, C, Sugaya, K, Perry, P, Nagamizu, K, Weiller, E, Baker, R, Malla, A

Get full text

The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability by Sheehan, DV, Lecrubier, Y, Harnett Sheehan, K, Janavs, J, Weiller, E, Keskiner, A, Schinka, J, Knapp, E, Sheehan, MF, Dunbar, GC

“…The Mini International Neuropsychiatric Interview (MINI) is a short diagnostic structured interview, developed in clinician (MINI-CR) and patient-rated…”
Get full text

P.2.e.019 Remission of manic and depressive symptoms with asenapine in patients with mixed episodes by Azorin, J.M, Weiller, E, Sapin, C

Get full text

P.3.d.079 Brexpiprazole (OPC-34712) efficacy and safety as maintenance therapy in adults with schizophrenia: Randomised, double-blind, placebo-controlled study by Fleischhacker, W.W, Hobart, M, Ouyang, J, Forbes, A, Pfister, S, McQuade, R, Carson, W.H, Sanchez, R, Nyilas, M, Weiller, E

Get full text

DSM-III-R Psychotic Disorders : procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI by AMORIM, P, LECRUBIER, Y, WEILLER, E, HERGUETA, T, SHEEHAN, D

Get full text

Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine by Boulenger, J.P., Hermes, A., Huusom, A.K.T., Weiller, E.

“…Abstract Objective: To investigate if treatment outcome for severely depressed patients depends on their baseline level of anxiety. Research design and…”
Get full text

Does baseline anxiety affect outcome of SSRI treatment in patients with severe depression? by Boulenger, J.P, Weiller, E

Get full text

Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care by Weiller, E, Bisserbe, J C, Maier, W, Lecrubier, Y

“…This study explored the prevalence, socio-demographic characteristics and severity of different anxiety syndromes in five European primary care settings, as…”
Get more information